- Home
- CDMO vs ORIC Comparison
CDMO vs ORIC Comparison
Compare CDMO & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDMO
- ORIC
- Stock Information
- Founded
- CDMO 1981
- ORIC 2014
- Country
- CDMO United States
- ORIC United States
- Employees
- CDMO N/A
- ORIC N/A
- Industry
- CDMO Biotechnology: Pharmaceutical Preparations
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- CDMO Health Care
- ORIC Health Care
- Exchange
- CDMO Nasdaq
- ORIC Nasdaq
- Market Cap
- CDMO 784.1M
- ORIC 633.7M
- IPO Year
- CDMO N/A
- ORIC 2020
- Fundamental
- Price
- CDMO $12.36
- ORIC $8.22
- Analyst Decision
- CDMO Buy
- ORIC Strong Buy
- Analyst Count
- CDMO 5
- ORIC 9
- Target Price
- CDMO $13.63
- ORIC $18.75
- AVG Volume (30 Days)
- CDMO 1.3M
- ORIC 294.2K
- Earning Date
- CDMO 12-10-2024
- ORIC 11-12-2024
- Dividend Yield
- CDMO N/A
- ORIC N/A
- EPS Growth
- CDMO N/A
- ORIC N/A
- EPS
- CDMO N/A
- ORIC N/A
- Revenue
- CDMO $150,445,000.00
- ORIC N/A
- Revenue This Year
- CDMO $19.05
- ORIC N/A
- Revenue Next Year
- CDMO $20.88
- ORIC N/A
- P/E Ratio
- CDMO N/A
- ORIC N/A
- Revenue Growth
- CDMO 6.75
- ORIC N/A
- 52 Week Low
- CDMO $5.65
- ORIC $6.33
- 52 Week High
- CDMO $12.48
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- CDMO 67.27
- ORIC 37.88
- Support Level
- CDMO $12.11
- ORIC $7.90
- Resistance Level
- CDMO $12.39
- ORIC $8.62
- Average True Range (ATR)
- CDMO 0.09
- ORIC 0.48
- MACD
- CDMO -0.05
- ORIC -0.15
- Stochastic Oscillator
- CDMO 89.29
- ORIC 17.96
About CDMO Avid Bioservices Inc.
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.